Chemtronics Konform AR CTAR-12 - Manual (Page 2)

Konform® AR - CTAR12, CTAR-12C
2. Hazards identification
See toxicological information (Section 11)
Medical conditions
aggravated by over-
exposure Pre-existing disorders involving any target organs mentioned in this MSDS as being at
risk may be aggravated by over-exposure to this product. :
Carcinogenicity : Contains material which can cause cancer. Risk of cancer depends on duration and
level of exposure.
Mutagenicity : No known significant effects or critical hazards.
Teratogenicity : No known significant effects or critical hazards.
Developmental effects : No known significant effects or critical hazards.
Chronic effects : Contains material that can cause target organ damage.
Fertility effects : No known significant effects or critical hazards.
Over-exposure signs/symptoms
Ingestion : Adverse symptoms may include the following:
Irritating to mouth, throat and stomach.
nausea or vomiting
Skin : Adverse symptoms may include the following:
irritation
redness
Eyes : Adverse symptoms may include the following:
pain or irritation
watering
redness
Inhalation : Adverse symptoms may include the following:
respiratory tract irritation
coughing
headache
dizziness/vertigo
drowsiness/fatigue
Target organs : Contains material which causes damage to the following organs: the nervous system,
eye, lens or cornea.
Contains material which may cause damage to the following organs: blood, kidneys,
lungs, the reproductive system, liver, heart, peripheral nervous system, upper
respiratory tract, skin, central nervous system (CNS).
n-butyl acetate 123-86-4 10 - 20
propyl acetate 109-60-4 10 - 20
2-methoxy-1-methylethyl acetate 108-65-6 10 - 20
ethanol 64-17-5 10 - 20
Butane 106-97-8 10 - 20
propane 74-98-6 10 - 20
butanone 78-93-3 2 - 5
3. Composition/information on ingredients
Name CAS number %
There are no additional ingredients present which, within the current knowledge of the supplier and in the
concentrations applicable, are classified as hazardous to health or the environment and hence require reporting
in this section.
2/13 0708 5/21/2013.